Search research articles
Contact Us
Filters
Showing results (541-550 of 595) with videos related to
Page
of 60
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2025
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study
F de Marinis, T M Kim, L Bonanno, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 29, 2023
SARS-CoV-2 perinatal transmission and neonatal outcomes across four different waves of COVID-19 pandemic: A nationwide prospective cohort study from the Italian Society of Neonatology
Lorenza Pugni, Beatrice Letizia Crippa, Francesco Raimondi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 24, 2023
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
Claudia Proto, Sara Manglaviti, Giuseppe Lo Russo, et al.
Frontiers in Oncology
|
February 9, 2023
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients
Arsela Prelaj, Edoardo Gregorio Galli, Vanja Miskovic, et al.
Iscience
|
September 2, 2025
Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophy
Jeremy Y Huang, Brian Freed, Martin Hanus, et al.
ESMO Open
|
June 15, 2024
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)
E G Pizzutilo, A G Agostara, S Oresti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 30, 2020
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status
Francesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri, et al.
Stem Cells Translational Medicine
|
February 28, 2015
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies
James A Heslop, Thomas G Hammond, Ilaria Santeramo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2024
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)
C Proto, M Ganzinelli, S Manglaviti, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records
Federica Corso, Vittoria Peppoloni, Laura Mazzeo, et al.
Page
of 60
Search research articles
Search
Showing results (541-550 of 595) with videos related to
Sort By:
Page
of 60
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2025
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study
F de Marinis, T M Kim, L Bonanno, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 29, 2023
SARS-CoV-2 perinatal transmission and neonatal outcomes across four different waves of COVID-19 pandemic: A nationwide prospective cohort study from the Italian Society of Neonatology
Lorenza Pugni, Beatrice Letizia Crippa, Francesco Raimondi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 24, 2023
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
Claudia Proto, Sara Manglaviti, Giuseppe Lo Russo, et al.
Frontiers in Oncology
|
February 9, 2023
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients
Arsela Prelaj, Edoardo Gregorio Galli, Vanja Miskovic, et al.
Iscience
|
September 2, 2025
Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophy
Jeremy Y Huang, Brian Freed, Martin Hanus, et al.
ESMO Open
|
June 15, 2024
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)
E G Pizzutilo, A G Agostara, S Oresti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 30, 2020
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status
Francesco Facchinetti, Giulia Mazzaschi, Fausto Barbieri, et al.
Stem Cells Translational Medicine
|
February 28, 2015
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies
James A Heslop, Thomas G Hammond, Ilaria Santeramo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2024
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)
C Proto, M Ganzinelli, S Manglaviti, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Combining Clinician Expertise with Prompt Engineering enhances Small Language Models Reliability for Cancer Entity Recognition in Electronic Health Records
Federica Corso, Vittoria Peppoloni, Laura Mazzeo, et al.
Page
of 60